The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Market Size Is Forecasted For The Predictive Genetic Testing And Consumer Genomics Market By 2030 Based On Its 2026 Value?
The predictive genetic testing and consumer genomics market has experienced rapid growth in recent years. It is anticipated to expand from $9.07 billion in 2025 to $10.49 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. This historical growth can be linked to factors such as increasing consumer health awareness, broader accessibility of genetic testing, the growing availability of affordable sequencing technologies, rising interest in ancestry testing, and the advancement of digital health ecosystems.
The predictive genetic testing and consumer genomics market is anticipated to expand significantly over the coming years, reaching a valuation of $18.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected expansion is driven by several factors, including a heightened demand for tailored preventive healthcare, an increase in pharmacogenomic testing, the broadening of consumer genomics platforms, greater integration with digital health applications, and stricter regulatory control over genetic data utilization. Key trends during this period are expected to encompass wider acceptance of direct-to-consumer genetic testing, increased utilization of digital health platforms, a growing desire for insights into preventive health, the proliferation of at-home sample collection kits, and a strengthened emphasis on data privacy and security.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp
Which Core Factors Are Supporting The Expansion Of The Predictive Genetic Testing And Consumer Genomics Market?
The growing understanding of personalized medicine is set to propel the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine describes a healthcare approach that tailors treatment and prevention strategies based on an individual’s genetic makeup, lifestyle, and environmental elements. Awareness regarding personalized medicine is increasing because it enhances treatment effectiveness by matching therapies to a patient’s specific biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, which allows for customized prevention, early detection, and treatment plans based on an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, marking a rise from 6 in 2022. Therefore, the expanding awareness about personalized medicine is boosting the growth of the predictive genetic testing and consumer genomics market.
What Are The Core Segment Classifications In The Predictive Genetic Testing And Consumer Genomics Market?
The predictive genetic testing and consumer genomics market covered in this report is segmented –
1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing
3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting
4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases
5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)
Subsegments:
1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics
2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk
3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization
4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening
Which Trends Are Guiding The Development Of The Predictive Genetic Testing And Consumer Genomics Market?
Leading companies operating in the predictive genetic counselling market are prioritizing the development of advanced solutions, such as the predictive genetic testing service, for the early detection of disease risk and to support informed clinical decision-making. The predictive genetic testing service is defined as a medical offering that examines an individual’s DNA to identify genetic variations linked to an elevated risk of developing specific inherited conditions or diseases in the future. For example, in August 2024, Genetic Technologies Limited, an Australia-based company that provides genomics-based health testing, launched the geneType Risk Assessment test. This test is a unique, comprehensive, multi-risk predictive genetic screening tool designed to assess an individual’s likelihood of developing serious conditions such as breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It combines clinically validated polygenic risk scores with non-genetic factors like age, family history, and clinical measurements to produce a personalized, actionable risk profile. It is engineered for proactive health management and additionally offers clear reports with tailored recommendations to guide preventive care and lifestyle choices in over 42 countries.
Who Are The Companies Shaping The Predictive Genetic Testing And Consumer Genomics Market Landscape?
Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation
Access The Complete Predictive Genetic Testing And Consumer Genomics Market Report:
Which Regional Market Leads The Predictive Genetic Testing And Consumer Genomics Market?
North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Predictive Genetic Testing And Consumer Genomics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp
Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company
Property Management Software Market 2026
https://www.thebusinessresearchcompany.com/report/property-management-software-market
Property Management Service Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report
Commercial Property Insurance Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model